Viewing Study NCT04759885



Ignite Creation Date: 2024-05-06 @ 3:46 PM
Last Modification Date: 2024-10-26 @ 1:57 PM
Study NCT ID: NCT04759885
Status: COMPLETED
Last Update Posted: 2022-07-12
First Post: 2020-11-30

Brief Title: Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep
Sponsor: NTC srl
Organization: NTC srl

Study Overview

Official Title: Efficacy and Safety of mAnniTol in Bowel Preparation Assessment of Adequacy and Presence of Intestinal levelS of Hydrogen and Methane During Elective Colonoscopy aFter mAnnitol or Standard Split 2-liter Polyethylene Glycol Solution Plus asCorbaTe - a Phase IIIII International Multicentre Randomized Parallel-group endoscOpist-bliNded Dose-findingNon-inferiority Study - SATISFACTION
Status: COMPLETED
Status Verified Date: 2022-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SATISFACTION
Brief Summary: The purpose of this dose findingcomparative efficacy study is to first single out the most appropriate dose of mannitol for bowel preparation phase II and subsequently demonstrate the non-inferiority of the efficacy of single dose mannitol vs standard split 2L PEG ASC Moviprep phase III in bowel preparation for colonoscopy
Detailed Description: Study Start and Study Completion dates relative to the Phase IIIII are reported here

Phase II Patients n 183

Date of first enrolment 22 June 2020
Date LPLV 12 November 2020

Phase III Patients n 703

Date of first enrolment 2 March 2021
Date LPLV 16 July 2021

Date on which the study was entered in the EudraCT database 13 October 2020

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2019-002856-18 EUDRACT_NUMBER None None